ENTITY
Global Cord Blood

Global Cord Blood (CO US)

20
Analysis
Health CareUnited States
Global Cord Blood Corporation operates as a life sciences enterprise. The Company provides collection of umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing, and stem cell storage services. Global Cord Blood also operates as cord blood banking operator. Global Cord Blood serves customers in China.
more
bullishChong Hing Bank
31 May 2021 13:47

(Mostly) Asia M&A: May 2021 Roundup

The average premium for the new deals announced (or first discussed) in May was ~41%, with a year-to-date average of ~31% (78 deals).

Logo
261 Views
Share
30 Apr 2021 08:00

(Mostly) Asia M&A: April 2021 Roundup

The average premium for the new deals announced (or first discussed) in April was ~13%, with a year-to-date average of ~30% (66 deals).

Logo
375 Views
Share
31 Mar 2021 11:29

(Mostly) Asia M&A: March 2021 Roundup

The average premium for the new deals announced (or first discussed) in March was ~31%, with a year-to-date average of ~31% (57 deals).

Logo
285 Views
Share
16 Mar 2021 15:24

Global Cord Blood: Haitong Raids The Bank

Despite a 9% gross spread to terms, I would not chase shares here. You have a broker oddly making the Offer; whereas a more suitable candidate...

Logo
373 Views
Share
18 Jun 2020 20:54

Golden Meditech (801 HK): Prescription Renewal

Back on 13 January 2017, Golden Meditech Holdings Ltd ("GMH", 801 HK) announced an Offer from Kam Yuen, the chairman & controlling shareholder...

Logo
478 Views
Share
x